The market is segmented based on
全球溃疡性结肠炎市场，按类型（溃疡性直肠炎、直肠乙状结肠炎、左侧结肠炎、全结肠炎或普遍性结肠炎和暴发性结肠炎）、药物类型（抗炎药物、氨基水杨酸盐、皮质类固醇、抗 TNF 生物制剂、免疫抑制剂、钙调磷酸酶抑制剂等）、分子类型（小分子和生物制剂）、给药途径（注射和口服）、分销渠道（医院药房、零售药房、药店等）划分 - 行业趋势和预测到 2030 年。
.
The Global Ulcerative Colitis Market size was valued at USD 7321.78 USD Million in 2023.
The Global Ulcerative Colitis Market is projected to grow at a CAGR of 5.7% during the forecast period of 2024 to 2030.
The major players operating in the market include Johnson &, Johnson ServicesInc. , Bayer AG , AbbVie Inc. , Merck &, Co.Inc. , Takeda Pharmaceutical Company Limited , GlaxoSmithKline plc. , F. Hoffmann-La Roche Ltd , Pfizer Inc. , Abbott , Astrazeneca , Sanofi , Allergan , CELGENE CORPORATION , Bristol-Myers Squibb Company , InDex Pharmaceuticals Holding AB .
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.
The data presented is for visualization purposes only and may not reflect actual results.